XML 70 R54.htm IDEA: XBRL DOCUMENT v3.25.2
Share-Based Compensation - Summary of the Option Unit Activity (Details)
$ / shares in Units, $ in Millions
 6 Months Ended
Jun. 30, 2025
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Weighted Average Remaining Contractual Term, Grants Vested 1 year 3 months 18 days
2021 Equity Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of units, grant outstanding beginning balance | shares 4,517,897
Number of grants, issued | shares 742,661
Number of grants, exercised | shares (18,986)
Number of grants, cancelled/forfeited | shares (69,864)
Number of units, grant outstanding ending balance | shares 5,171,708
Number of grants, vested | shares 2,762,791
Number of grants, unvested | shares 2,408,917
Weighted average exercise price, grant outstanding beginning balance | $ / shares $ 14.38
Weighted average exercise price, grants exercised | $ / shares 13.55
Weighted average exercise price, grants issued | $ / shares 15.27
Weighted average exercise price, cancelled/forfeited | $ / shares 14.02
Weighted average exercise price, grant outstanding ending balance | $ / shares 14.51
Weighted average exercise price, grants vested | $ / shares 13.67
Weighted average exercise price, grants unvested | $ / shares $ 15.48
Weighted Average Remaining Contractual Term, Grants Outstanding 7 years 3 months 18 days
Weighted Average Remaining Contractual Term, Grants Vested 6 years 3 months 18 days
Aggregate Intrinsic Value, grants outstanding | $ $ 12.2
Aggregate Intrinsic Value, grants vested | $ $ 8.1
First Advantage Corporation [Member] | 2020 Equity Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of units, grant outstanding beginning balance | shares 1,602,966
Number of grants, exercised | shares (216,805)
Number of grants, cancelled/forfeited | shares (29,074)
Number of units, grant outstanding ending balance | shares 1,357,087
Number of grants, vested | shares 941,905
Number of grants, unvested | shares 415,182
Weighted average exercise price, grant outstanding beginning balance | $ / shares $ 5.15
Weighted average exercise price, grants exercised | $ / shares 5.11
Weighted average exercise price, cancelled/forfeited | $ / shares 5.19
Weighted average exercise price, grant outstanding ending balance | $ / shares 5.15
Weighted average exercise price, grants vested | $ / shares 5.13
Weighted average exercise price, grants unvested | $ / shares $ 5.2
Weighted Average Remaining Contractual Term, Grants Outstanding 4 years 8 months 12 days
Weighted Average Remaining Contractual Term, Grants Vested 4 years 8 months 12 days
Aggregate Intrinsic Value, grants outstanding | $ $ 15.6
Aggregate Intrinsic Value, grants vested | $ $ 10.8